AMED

1 BTC

=

- USD

Amedisys Inc logo

Amedisys Inc

AMED🇺🇸
Coming Soon
0.00%

As of June 1, 2026 at 24:05 UTC

Chart

About Amedisys Inc

Sector
SERVICES-HOME HEALTH CARE SERVICES
Headquarters
BATON ROUGE
Employees (FY)
19,000
Listed
1994-08-17
FIGI
BBG000B9ZV28

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Market Statistics

Market Capâ‚¿ 45.05K
24h Volume-
24h Change0.00%
7d Change0.00%
1m Change0.00%

Trading Metrics

Trading Volume (BTC)-

How to Buy AMED

1

Create Your Account

Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.

2

Start Your Trade

From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.

3

Buy AMED

Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.

New to Tokenized Assets? Learn more in our Help Center.

Latest News

5 articles
Benzinga favicon
Benzingawww.benzinga.com

UnitedHealth Group agreed to divest 164 healthcare facilities as part of a DOJ settlement related to its Amedisys acquisition, impacting its Q2 earnings which missed analyst expectations.

Related:
Benzinga favicon
Benzingawww.benzinga.com

UnitedHealth Group agreed to divest over 160 healthcare facilities to resolve antitrust concerns surrounding its $3.3 billion Amedisys acquisition. The Department of Justice settlement includes a $1.1 million fine against Amedisys for inaccurate regulatory filings.

Related:
The Motley Fool favicon
The Motley Foolwww.fool.com

Amedisys reported Q2 2025 earnings that exceeded market expectations, with strong revenue growth and improved operational efficiency, despite merger-related expenses associated with the pending UnitedHealth Group transaction.

Related:
Investing.com favicon
Investing.comwww.investing.com

UnitedHealth Group (UNH) faces regulatory probes, leadership changes, and lawsuits, leading to a 31% stock decline. However, the company's dominant market position, vertically integrated ecosystem, and strong financials suggest it may be too big to break, similar to Boeing's position in the aviation industry.

Related:
Investing.com favicon
Investing.comwww.investing.com

UnitedHealth's stock price plummeted after Q1 results, but analysts now consider it undervalued with significant upside potential and a strong dividend yield, making it a potential buying opportunity.

Related:

1 BTC

=

- USD

Loading market data...

Roxom | AMED - Amedisys Inc